Recent research from Brazil highlights potential risks associated with the long-term use of proton pump inhibitors (PPIs), a class of medications commonly used to treat conditions such as ulcers and acid reflux. Conducted by scientists at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC), the study published in ACS Omega suggests that prolonged use of PPIs, including popular drugs like omeprazole, pantoprazole, and esomeprazole, may interfere with the body’s absorption of essential nutrients.
The study specifically examined the effects of omeprazole on the absorption of key minerals in rats over various treatment durations. Findings indicated that the medication altered mineral distribution, leading to increased calcium levels in the bloodstream and decreased iron levels, which could elevate the risk of conditions such as osteoporosis and anemia. Researchers noted shifts in immune system cell activity as well.
Concerns regarding the overuse of PPIs have been amplified by the Brazilian Health Regulatory Agency’s (ANVISA) recent approval for the over-the-counter sale of 20mg omeprazole. While ANVISA aims to promote responsible use of the drug, experts caution that easier access may encourage self-medication beyond the recommended 14-day treatment limit, potentially exacerbating nutrient absorption issues.
The study underscores the importance of medical supervision in the use of PPIs, particularly as newer formulations may have even stronger effects. Researchers emphasize the need for health professionals to evaluate the necessity of these medications on a case-by-case basis, considering the possibility of nutrient supplementation when necessary. Overall, the findings contribute to a growing understanding of the implications of long-term PPI use on nutrient absorption.